Paperpal Prime Logo

Hepatology Communications : Impact Factor & More

eISSN: 2471-254XpISSN: 2471-254X
JournalOpen Access

Key Metrics

CiteScore
7.7
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
Scite Index
0.91 5-Year SI
SNIP
1.26
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Hepatology Communications

Hepatology Communications Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher JOHN WILEY & SONS LTD
Language English
Frequency Monthly
Article Processing ChargesUSD 2700
Publication Time8
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorAmerican Association for the Study of Liver Diseases
FrequencyMonthly
Publication Start Year2017
Publisher URLVisit website
Website URLVisit website
Publication Details
Publication Time 8
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Hepatology Communications ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Hepatology Communications

Challenges in the care of rare vascular liver diseases: Insights from patients, health care providers, and patient organizations.
  • 1 Sep 2026
  • Hepatology communications
Spatiotemporal dynamics of the tumor microenvironment in hepatocellular carcinoma during combination immunotherapy.
  • 1 Sep 2026
  • Hepatology communications
Stigmatizing language in alcohol-associated cirrhosis open notes: Persistent but declining.
  • 1 Sep 2026
  • Hepatology communications
Sequential FIB-4-based testing limits detection of fibrotic MASLD despite optimized ELF thresholds.
  • 1 Sep 2026
  • Hepatology communications
Contemporary global epidemiology of cirrhosis.
  • 1 Aug 2026
  • Hepatology communications
Circulating multi-omic signature of disease severity and cholangiocarcinoma in primary sclerosing cholangitis.
  • 1 Aug 2026
  • Hepatology communications
Challenges in the care of rare vascular liver diseases: Insights from patients, health care providers, and patient organizations.
  • 1 Sep 2026
  • Hepatology communications
Spatiotemporal dynamics of the tumor microenvironment in hepatocellular carcinoma during combination immunotherapy.
  • 1 Sep 2026
  • Hepatology communications
Stigmatizing language in alcohol-associated cirrhosis open notes: Persistent but declining.
  • 1 Sep 2026
  • Hepatology communications
Sequential FIB-4-based testing limits detection of fibrotic MASLD despite optimized ELF thresholds.
  • 1 Sep 2026
  • Hepatology communications
Contemporary global epidemiology of cirrhosis.
  • 1 Aug 2026
  • Hepatology communications
Circulating multi-omic signature of disease severity and cholangiocarcinoma in primary sclerosing cholangitis.
  • 1 Aug 2026
  • Hepatology communications

FAQs on Hepatology Communications